NL1001348C2 - Polypeptide comprising glycosyl-phosphatidyl:inositol structure - Google Patents

Polypeptide comprising glycosyl-phosphatidyl:inositol structure

Info

Publication number
NL1001348C2
NL1001348C2 NL1001348A NL1001348A NL1001348C2 NL 1001348 C2 NL1001348 C2 NL 1001348C2 NL 1001348 A NL1001348 A NL 1001348A NL 1001348 A NL1001348 A NL 1001348A NL 1001348 C2 NL1001348 C2 NL 1001348C2
Authority
NL
Netherlands
Prior art keywords
polypeptide
recombinant
glycosyl
phosphatidyl
sequence
Prior art date
Application number
NL1001348A
Other languages
English (en)
Dutch (nl)
Inventor
Nicolas Joseph Fasel
Christophe Dominique Reymond
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/428,616 priority Critical patent/US6113917A/en
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Priority to IL11802196A priority patent/IL118021A0/xx
Priority to PL96323078A priority patent/PL323078A1/xx
Priority to JP8532179A priority patent/JPH11504215A/ja
Priority to AU56481/96A priority patent/AU714808B2/en
Priority to EP96913528A priority patent/EP0826050A1/en
Priority to CZ19973378A priority patent/CZ291013B6/cs
Priority to CA002218987A priority patent/CA2218987A1/en
Priority to PCT/EP1996/001744 priority patent/WO1996034105A1/en
Priority to HU9802238A priority patent/HUP9802238A3/hu
Priority to NZ335929A priority patent/NZ335929A/xx
Priority to NZ307195A priority patent/NZ307195A/xx
Priority to BR9604989-8A priority patent/BR9604989A/pt
Application granted granted Critical
Publication of NL1001348C2 publication Critical patent/NL1001348C2/xx
Priority to NO974924A priority patent/NO974924L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL1001348A 1995-04-25 1995-10-05 Polypeptide comprising glycosyl-phosphatidyl:inositol structure NL1001348C2 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity
IL11802196A IL118021A0 (en) 1995-04-25 1996-04-23 Modified polypeptides for enhanced immunogenicity
HU9802238A HUP9802238A3 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
AU56481/96A AU714808B2 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
EP96913528A EP0826050A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
CZ19973378A CZ291013B6 (cs) 1995-04-25 1996-04-25 Modifikované polypeptidy vykazující zvýąenou imunogenitu
PL96323078A PL323078A1 (en) 1995-04-25 1996-04-25 Modified polypeptides of enchanced immunogenecity
PCT/EP1996/001744 WO1996034105A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
JP8532179A JPH11504215A (ja) 1995-04-25 1996-04-25 免疫原性の高められた修飾ポリペプチド
NZ335929A NZ335929A (en) 1995-04-25 1996-04-25 Use of a recombinant polypeptide having a glycosyl-phosphatidylinositol anchor for inducing an immune response
NZ307195A NZ307195A (en) 1995-04-25 1996-04-25 Recombinant polypeptides containing a glycosyl-phosphatidylinositol anchor having enhanced immunogencity against parasites
BR9604989-8A BR9604989A (pt) 1995-04-25 1996-04-25 Polipeptídeos modificados para imunogenicidade aperfeiçoada e processo de sua produção
CA002218987A CA2218987A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
NO974924A NO974924L (no) 1995-04-25 1997-10-24 Modifiserte polypeptider med öket immunogenisitet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity
EP95201066 1995-04-25

Publications (1)

Publication Number Publication Date
NL1001348C2 true NL1001348C2 (en) 1996-10-28

Family

ID=26139248

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1001348A NL1001348C2 (en) 1995-04-25 1995-10-05 Polypeptide comprising glycosyl-phosphatidyl:inositol structure

Country Status (15)

Country Link
US (1) US6113917A (ja)
EP (1) EP0826050A1 (ja)
JP (1) JPH11504215A (ja)
AU (1) AU714808B2 (ja)
BR (1) BR9604989A (ja)
CA (1) CA2218987A1 (ja)
CZ (1) CZ291013B6 (ja)
HU (1) HUP9802238A3 (ja)
IL (1) IL118021A0 (ja)
NL (1) NL1001348C2 (ja)
NO (1) NO974924L (ja)
NZ (1) NZ307195A (ja)
PL (1) PL323078A1 (ja)
WO (1) WO1996034105A1 (ja)
ZA (1) ZA963269B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026911A1 (en) * 1996-01-29 1997-07-31 Georgetown University Malaria vaccine based upon the addition of a msa1 peptide
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
KR20050035511A (ko) * 2001-10-13 2005-04-18 아스테리온 리미티드 폴리펩타이드들을 포함하는 글리코실포스파티딜이노시톨
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
BR0312985A (pt) 2002-07-26 2005-06-21 Inst Medical W & E Hall Métodos para extrair ou induzir, em um mamìfero, uma resposta imune dirigida a um parasita, para tratar de modo terapêutico ou profilático um mamìfero para infecção por parasitas, para o tratamento e/ou a profilaxia de uma condição doentia de mamìfero, uso de uma composição,composição, composição de vacina, composição farmacêutica, anticorpo para inibir, parar ou retardar o inìcio ou progressão de uma condição doentia de mamìfero, uso de um anticorpo, métodos para detectar, em uma amostra bológica, uma molécula imunointerativa dirigida a um microorganismo e para detectar, monitorar ou de outra forma avaliar uma resposta imune dirigida a um microorganismo em um indivìduo, kit modular, método para analisar, projetar e/ou modificar um agente capaz de interagir com um sìtio de ligação de molécula imunointerativa anti-gpi glicano, e, uso do agente
WO2004090135A2 (en) * 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
US20080026008A1 (en) * 2006-07-27 2008-01-31 Clark Tibbs Bacteriophage DNA vaccine vector

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020806A2 (en) * 1991-05-17 1992-11-26 Rmf Dictagene S.A. Dictyostelid expression vector and method for expressing a desired protein
WO1995022614A1 (en) * 1994-02-17 1995-08-24 Finep-Financiadora De Estudos E Projetos Production of glycosylphosphatidylinositol-anchored recombinant proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020806A2 (en) * 1991-05-17 1992-11-26 Rmf Dictagene S.A. Dictyostelid expression vector and method for expressing a desired protein
WO1995022614A1 (en) * 1994-02-17 1995-08-24 Finep-Financiadora De Estudos E Projetos Production of glycosylphosphatidylinositol-anchored recombinant proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PEARCE E. J. ET AL.: "Three major surface antigens of Schistosoma mansoni are linked to the membrane by glycosylphosphatidylinositol", JOURNAL OF IMMUNOLOGY, vol. 142, no. 3, 1 February 1989 (1989-02-01), BALTIMORE US, pages 979 - 984 *
REYMOND C D ET AL: "Anchoring of an immunogenic Plasmodium falciparum circumsporozoite protein on the surface of Dictyostelium discoideum.", JOURNAL OF BIOLOGICAL CHEMISTRY 270 (21). 1995. 12941-12947 *
VAI M ET AL: "ISOLATION AND DEDUCED AMINO ACID SEQUENCE OF THE GENE ENCODING GP115 A YEAST GLYCOPHOSPHOLIPID-ANCHORED PROTEIN CONTAINING A SERINE-RICH REGION.", J BIOL CHEM 266 (19). 1991. 12242-12248 *

Also Published As

Publication number Publication date
HUP9802238A2 (hu) 1999-01-28
JPH11504215A (ja) 1999-04-20
NO974924D0 (no) 1997-10-24
CZ291013B6 (cs) 2002-11-13
BR9604989A (pt) 1999-11-30
AU714808B2 (en) 2000-01-13
NZ307195A (en) 1999-07-29
NO974924L (no) 1997-12-19
AU5648196A (en) 1996-11-18
IL118021A0 (en) 1996-08-04
PL323078A1 (en) 1998-03-02
ZA963269B (en) 1996-10-25
CZ337897A3 (cs) 1998-04-15
WO1996034105A1 (en) 1996-10-31
CA2218987A1 (en) 1996-10-31
HUP9802238A3 (en) 2000-03-28
EP0826050A1 (en) 1998-03-04
US6113917A (en) 2000-09-05

Similar Documents

Publication Publication Date Title
PT74811B (en) Bacillus cloning vectors recombinant dna molecules bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby
EP1619202A3 (en) immunotherapeutic methods using epitopes of wt-1 and gata-1
EP0962467A4 (en) ANTIBODIES AGAINST HUMAN PARATHORMON RELATED PEPTIDES
IL62553A0 (en) Vectors comprising dna sequences and methods for producing recombinant dna molecules and cloning vectors
NL1001348C2 (en) Polypeptide comprising glycosyl-phosphatidyl:inositol structure
IE883612L (en) Vectors and compounds for direct expression of activated human protein c
AU5698686A (en) Promotors of filamentous fungi and use thereof
NO176799C (no) DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
DK0524906T3 (da) DNA-kodende for prolyl-endopeptidase samt dets anvendelse
AR012499A1 (es) Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin
SE8204811D0 (sv) Dna fragment comprising a signal sequence
DK0929677T3 (da) Rekombinant fremgangsmåde til fremstilling af et fuldstændigt malaria-antigen GP190/MSP1
HUP0003541A2 (hu) Expressziós vektor polipeptidek javított hatékonyságú előállítására élesztőben
EP0146903A3 (en) Production of a vector encoding a novel hybrid interferon species
GB8615263D0 (en) Light inducible promoter
HUT69139A (en) Method for producing dictyostelid expression vector and expressing a desired protein
ES8503373A1 (es) Un procedimiento de preparacion de un vector de transferencia de adn.
NZ304789A (en) Genes encoding lymphocyte interferon regulatory factory (lsirf) polypeptides that are transcription factors and specific antibodies to them
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
WO1988006186A3 (en) cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
NO179373C (no) Rekombinant vektor istand til å uttrykke et glykoprotein, transformant som uttrykker et glykoprotein og fremgangsmåte for fremstilling av et glykoprotein
JPS6474989A (en) Dna to code human lysozyme

Legal Events

Date Code Title Description
PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20060501